Artiva Biotherapeutics Q3 EPS $(0.92) Misses $(0.91) Estimate
Artiva Biotherapeutics Q3 EPS $(0.92) Misses $(0.91) Estimate
Artiva生物醫藥第三季度每股收益爲$(0.92)，低於$(0.91)的預估
Artiva Biotherapeutics (NASDAQ:ARTV) reported quarterly losses of $(0.92) per share which missed the analyst consensus estimate of $(0.91) by 1.1 percent. This is a 156.79 percent decrease over earnings of $1.62 per share from the same period last year.
Artiva生物醫藥（納斯達克股票代碼:ARTV）報告每股$(0.92)的季度虧損，較分析師共識預估$(0.91)低1.1%。這相比去年同期每股盈利$1.62，下降了156.79%。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間